Al-Modawat Specialized Medical Co. (9594.SR)
SAR 15.84
(4.9%)
SAR 15.84
(4.9%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | 13.59 Million | 4.42 Million | 2.27 Million |
| Net Income | 18.59 Million | 10.31 Million | -2.2 Million |
| Depreciation & Amortization | 3.65 Million | 2.1 Million | 1.92 Million |
| Deferred income taxes | - | - | - |
| Stock-based compensation | - | - | - |
| Change in working capital | -12.8 Million | -10.12 Million | 1.47 Million |
| Other non-cash items | 4.15 Million | 16.2 Million | 470.64 Thousand |
| Investing Cash Flow | -3.91 Million | -2.78 Million | -4.53 Million |
| Investments in PPE | -3.91 Million | -2.78 Million | -4.53 Million |
| Acquisitions | - | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | -3.91 Million | -8409.00 | -3600.00 |
| Financing Cash Flow | -10.79 Million | -7.01 Million | 6.89 Million |
| Debt repayment | -646.82 Thousand | -1.58 Million | -7.41 Million |
| Dividends payments | -9.35 Million | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | - | - | - |
| Other Financing Activities | -796.01 Thousand | -666.19 Thousand | - |
| Accounts receivables | -16.18 Million | -7.65 Million | 2.85 Million |
| Accounts payables | - | -1.53 Million | -14.81 Thousand |
| Inventory | -1.66 Million | -682.18 Thousand | 1.61 Million |
| Other working capital | 5.04 Million | -261.62 Thousand | -2.97 Million |
| Cash at beginning of period | 1.39 Million | 6.76 Million | 2.12 Million |
| Cash at end of period | 274.85 Thousand | 1.39 Million | 6.76 Million |
| Capital Expenditure | -3.91 Million | -2.78 Million | -4.53 Million |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | -1.11 Million | -5.37 Million | 4.63 Million |
| Free Cash Flow | 9.67 Million | 1.64 Million | -2.26 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.58 Million | 1.58 Million | 18.59 Million | 3.83 Million | 3.83 Million | 10.93 Million |
| Depreciation & Amortization | 1.2 Million | 1.2 Million | 3.65 Million | 914.87 Thousand | 911.9 Thousand | 1.83 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -4.84 Million | -4.84 Million | -12.8 Million | -4.51 Million | -4.51 Million | -6.5 Million |
| Other non-cash items | 941.95 Thousand | 941.95 Thousand | 4.15 Million | 2.04 Million | 2.04 Million | 17.57 Million |
| Investing Cash Flow | -1.65 Million | -1.65 Million | -3.91 Million | -1.53 Million | -1.53 Million | -853.62 Thousand |
| Investments in PPE | -1.66 Million | -1.66 Million | -3.91 Million | -1.53 Million | -1.53 Million | -853.62 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 14.07 Thousand | 14.07 Thousand | - | - | - | - |
| Financing Cash Flow | 15.01 Million | 15.01 Million | -10.79 Million | -3.36 Million | -3.36 Million | -3.66 Million |
| Debt repayment | - | - | -646.82 Thousand | - | - | -1.77 Million |
| Dividends payments | -9.26 Million | -9.26 Million | -9.35 Million | -2.27 Million | -2.27 Million | -4.79 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 24.27 Million | 24.27 Million | -796.01 Thousand | -1.09 Million | -1.09 Million | 369.03 Thousand |
| Accounts receivables | 261.26 Thousand | 261.26 Thousand | -16.18 Million | -4.7 Million | -4.7 Million | -7.32 Million |
| Accounts payables | - | - | - | - | - | -2.4 Million |
| Inventory | -505.24 Thousand | -505.24 Thousand | -1.66 Million | 56.53 Thousand | 56.53 Thousand | -1.78 Million |
| Other working capital | -4.6 Million | -4.6 Million | 5.04 Million | 131.2 Thousand | 131.2 Thousand | 5.01 Million |
| Cash at beginning of period | - | - | 1.39 Million | - | - | 1.39 Million |
| Cash at end of period | 12.24 Million | 12.24 Million | 274.85 Thousand | -2.62 Million | -2.62 Million | 5.52 Million |
| Capital Expenditure | -1.66 Million | -1.66 Million | -3.91 Million | -1.53 Million | -1.53 Million | -853.62 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 12.24 Million | 12.24 Million | -1.11 Million | -2.62 Million | -2.62 Million | 4.13 Million |
| Free Cash Flow | -2.78 Million | -2.78 Million | 9.67 Million | 744.41 Thousand | 744.41 Thousand | 7.79 Million |
WAY
ASTEC
SASKEN
PLASTIBLEN
FIPP
BETR